
ajp@psych.org
For verified host and producer emails, sign up to view.
Episodes: 231
Frequency: Monthly
Rating: 3.9/5.0
Estimated listeners: 1k-10k
Gender skew: Male
Location: USA
YouTube: 20.1k subscribers
ajp@psych.org
For verified host and producer emails, sign up to view.
Dr. Ned Kalin - Editor-in-Chief of The American Journal of Psychiatry (AJP) and host of AJP Audio; leads portions of each episode including issue-level context and discussion. (Specific CV details not provided in ...
Dr. Alan Schatzberg - Low-dose Buprenorphine Adjunctive Strategy After Ketamine For Suicidal Ideation; Disparity Between Ideation Vs Antidepressant Ratings; Ethics And Future Research Directions.
Dr. Jason Tucciarone - Low-dose Buprenorphine Following Ketamine For Suicidal Ideation In Major Depressive Disorder; Trial Design, Results, Limitations, And Clinical Implications.
Dr. Mara Oquendo - Future Of DSM Strategic Vision, Including Living Document Approach, Incorporation Of Science/biomarkers, Documentation/coding Changes, And Lived Experience.
Dr. Eduardo Butelman - Sex-based Differences In Psychiatric Comorbidities Among Patients With Substance Use Disorders; Mechanisms, Response Patterns, Limitations, And Implications For Research.
June 2026: Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
June 01, 2026
Dr. Jason Tucciarone and Dr. Alan Schatzberg (Stanford University, Stanford, CA) join AJP Audio to discuss the use of low-dose buprenorphine as an adjunctive therapy to extend the anti-suicidal effects of ketamine treatment in patients with major depressive disorder and suicidal ideation. AJP Editor-in-Chief Dr. Ned Kalin joins to discuss the rest of the June issue of the Journal, which takes a close look at issues surrounding suicide and severe depression. 01:20 Tucciarone and Schatz...
Special Episode: The Future of DSM
May 15, 2026
In this special episode of AJP Audio, AJP Editor-in-Chief Dr. Ned Kalin is joined by Dr. María Oquendo (Perelman School of Medicine at the University of Pennsylvania, Philadelphia), chair of APA's Future DSM Strategic Committee to discuss a series of commentaries published in the May issue of the Journal discussing the strategic vision for the future of DSM. 00:39 Oquendo interview 03:07 Size of the response 04:18 Feedback 06:04 Incorporating the feedback 07:57 Emphasizing sci...
May 2026: Psychiatric Comorbidities in Substance Use Disorders: Sex-Based Differences in a National Real-World Clinical Sample
May 01, 2026
Dr. Eduardo Butelman (Icahn School of Medicine at Mount Sinai, New York) joins AJP Audio to discuss the varying incidence of psychiatric comorbidities across patients diagnosed with substance use disorders. Afterwards, AJP Editor-in-Chief Dr. Ned Kalin joins the podcast to discuss the rest of the May issue, which includes a discussion on the future of the DSM. 00:53 Butelman interview 02:23 Mechanisms of difference between males and females 04:04 Patterns of response between ...
Try us risk free with a FREE 3 days trial.
Join hundreds of PR teams using Podseeker to pitch and land bookings